Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma

European Archives of Oto-Rhino-Laryngology

Volumn 262, Issue 9, 2005, Pages 731-736

  Olszewska, Ewa ^a   Lautermann, Jürgen ^a   Koc, Can ^b   Schwaab, Matthias ^a   Dazert, Stefan ^a   Hildmann, Henning ^a   Sudhoff, Holger ^a  

^a St Elisabeth Hospital Bochum   (Germany)

^b KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Cholesteatoma; Cytokeratins; Epidermis; Middle ear

Indexed keywords

CYTOKERATIN; CYTOKERATIN 10; CYTOKERATIN 14; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 34BETAE12; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CHOLESTEATOMA; CLINICAL ARTICLE; CONTROLLED STUDY; EARDRUM; EARDRUM PERFORATION; FEMALE; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

CHILD; CHILD, PRESCHOOL; CHOLESTEATOMA, MIDDLE EAR; EAR, MIDDLE; EPIDERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MUCOUS MEMBRANE;

EID: 26444613815     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-004-0875-0     Document Type: Article

References (53)

1. Akimoto R, Pawankar R, Yagi T, Baba S (2000) Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec 62:257-265
2. Broekaert D, Boedts D (1993) The proliferative capacity of the keratinizing annular epithelium. Acta Otolaryngol (Stockh) 113:345-348
3. Broekaert D, Cornille A, Eto E, Leigh I, Ramaekers F, Van Muijen G, Coucke P, De Bersaques J, Kluyskens P, Gillis E (1988) A comparative immunohistochemical analysis of the cytokeratin and vimentin expression in middle ear mucosa and cholesteatoma, and in epidermis. Virchows Arch A Pathol Anat 413:39-51
4. Broekaert D, Coucke P, Leperque S, Ramaekers F, Van Muijen G, Boedts D, Leigh I, Lane B (1992) Immunohistochemical analysis of the CK expression in middle ear cholesteatoma and related epithelial tissues. Ann Otol Rhinol Laryngol 101:931-938
5. Bujia J, Schilling V, Holly A, Stammberger M, Kastenbauer E (1993) Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol (Stockh) 113:364-368
6. Chao WY, Huang CC (1989) A immunocytochemical study of cytokeratin expression in human middle ear cholesteatoma. Arch Otorhinolaryngol 246:37-42
7. Derlacki EL, Clemis JD (1965) Congenital cholesteatoma of the middle ear and mastoid. Ann Otol Rhinol Laryngol 74:706-727
8. Eichner R, Sun T-T, Aebi U (1986) The role of keratin subfamilies and keratin pairs in the formation on human epidermal intermediate filaments. J Cell Biol 102:1767-1777
9. Forsen JW (2000) Chronic disorders of the middle ear and mastoid. In: Wetmore RF, Muntz HR, McGill TJ (eds) Pediatric otolaryngology: principles and pathways. Thieme, New York, pp 281-304
10. Grundfast KM, Ahuja GS, Parisier SC, Culver SM (1995) Delayed diagnosis and fate of congenital cholesteatoma (keratoma). Arch Otolaryngol Head Neck Surg 121:903-907
11. Hildmann H, Sudhoff H (1999) Cholesteatoma in children. Int J Pediatr Otorhinolaryngol 5 [Suppl 1]: S81-86
12. Huang J, Yi Z, Lin G (1996) Altered cytokeratin expression of the epidermoid formation of the tympanic cavity of human fetuses. Zhonghua Er Bi Yan Hou Ke Za Zhi 31:72-74
13. Kasper M, Moll R, Stosiek P, Karsten U (1988) Patterns of cytokeratin and vimentin expression in the human eye. Histochemistry 89:369-377
14. Kim CC, Chung JW (1990) Morphologic and biologic changes of experimentally induced cholesteatoma in Mongolian gerbils with anticytokeratin and lectin study. Am J Otol 20:13-18
15. Kim H-J, Tinling SP, Chole RA (2002) Increased proliferation and migration of epithelium in advancing experimental cholesteatomas. Otol Neurotol 23:840-844
16. Kim HJ, Tinling SP, Chole RA (2002) Expression patterns of cytokeratins in cholesteatomas: evidence of increased migration and proliferation. J Korean Med Sci 17:381-388
17. Kojima H, Miyazaki H, Shiwa M, Tanaka Y, Moriyama H (2001) Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length. Laryngoscope 111:867-873
18. Koltai PJ, Nelson M, Castellon RJ, Garabedian EN, Triglia JM, Roman S, Roger G (2002) The nature history of congenital cholesteatoma. Arch Otolaryngol Head Neck Surg 128:804-809
19. Laskiewicz B, Chalstrey S, Gatland DJ, Jones N, Michaels L (1991) Congenital cholesteatoma. J Laryngol Otol 105:995-998
20. Lee RJ, Sidey C, Narula RA, James RFL (1994) The nature of the epithelium in acquired cholesteatoma: part 3-cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture. Clin Otolaryngol 19:516-520
21. Levenson M, Michaels L, Parisier C (1989) Congenital cholesteatoma of the middle ear in children. Otolaryngol Clin N Am 22:941-954
22. Liang JN, Chrobok V, Michaels L, Wright A (2000) Incidence and cytokeratin analysis of the epidermoid formation. Registry 8:1-4
23. Liang J, Michaels L, Wright A (2003) Immunohistochemical characterization of the epidermoid formation in the middle ear. Laryngoscope 113:1007-1014
24. Liu J, Rutter MJ, Choo DI, Willging JP (2000) Congenital cholesteatoma of the middle ear. Clin Pediatr 39:549-551
25. Mansbridge JN, Knapp AM (1987) Changes in keratinocyte maturation during wound healing. J Invest Dermatol 89:253-263
26. Mare SD, Jong ED, Van Erp PEJ (1990) Markers for proliferation and keratinization in the margin of the active psoriatic lesion. Br J Dermatol 122:469-475
27. Michaels L (1986) An epidermoid formation in the developing middle ear: possible source of cholesteatoma. J Otolaryngol 15:169-174
28. Michaels L (1988) Evaluation of the epidermoid formation and its role in the development of the middle ear and tympanic membrane during the first trimester. J Otolaryngol 17:22-28
29. Moll R, Franke WW, Schiller DL (1982) The catalog of human CK: patterns of the expression in normal epithelia, tumors and cultured cells. Cell 31:11-24
30. Nelson M, Roger G, Koltai PJ, Garabedian EN, Triglia JM, Roman S, Castellon RJ, Hammel JP (2002) Congenital cholesteatoma. 128:810-814
31. Potsic WP, Korman SB, Samadi DS, Wetmore RF (2002) Congenital cholesteatoma: 20 years' experience at the Children's Hospital of Philadelphia. Otolaryngol Head Neck Surg 126:409-414
32. Ramaekers F, Huysman A, Moesker O, Kant A, Jap P, Herman C, Vooijs P (1983) Monoclonal antibody to keratin filaments specific for glandular epithelia and their tumors. Use in surgical pathology. Lab Invest 49:353-361
33. Rashad U, Hawthorne M, Kumar U, Welsh A (1999) Unusual cases of congenital cholesteatoma of the ear. J Laryngol Otol 131:52-54
34. Rosenfeld RM, Moura RL, Bluestone CD (1992) Predictors of residual-recurrent cholesteatoma in children. Arch Otolaryngol Head Neck Surg 118:384-439
35. Sade J (1971) Cellular differentiation in the middle ear lining. Ann Otol Rhinol Laryngol 80:376-384
36. Sanna M, Zini C, Scandellari R, Jemmi G (1984) Residual and recurrent cholesteatoma in closed tympanoplasty. Am J Otol 5:277-282
37. Sheehy JL (1978) Management of cholesteatoma in children. Adv Otorhinolaryngol 23:58-64
38. Shinkawa H, Hozawa J, Usami S, Saito (1993) Immunohistochemical study on CK and vimentin expression in congenital cholesteatoma. In: Nakano Y (ed) Cholesteatoma and mastoid surgery. Kugler, Amsterdam, pp 155-166
39. Shohet JA, de Jong AL (2002) The management of pediatric cholesteatoma. Otolaryngol Clin N Am 35:841-851
40. Sobol SM, Reichert TJ, Faw KD, Stroud MH, Spector GJ, Ogura JH (1980) Intramembranous and mesotympanic cholesteatomas associated with an intact tympanic membrane in children. Ann Otol Rhinol Laryngol 89:312-317
41. Sun TT, Eichner R, Nelson WG, Tseng SCG, Weiss RA, Jarvinen M, Woodcock-Mitchell J (1983) Keratin classes: molecular markers for different types of epithelial differentiation. J Invest Dermatol 81:109s-115s
42. Sun TT, Tseng SCG, Huang AHW, Cooper D, Schermer A, Lynch MH, Weiss R, Eichner R (1985) Monoclonal antibodies studies of mammalian epithelial keratins: a review. Ann NY Acad Sci 455:307-329
43. Sudhoff H, Hildmann H (2003) Current theories on the origin of cholesteatoma. HNO 51:71-82
44. Sudhoff H, Tos M (2000) Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retraction theory and proliferation theory. Am J Otol 21:786-792
45. Sudhoff H, Liang J, Dazert S, Borkowski G, Michaels L (1999) Zur Rolle der Epidermoid Formationen in der Pathogenese des kongenitalen Cholesteatoms - eine aktuelle Übersicht. Laryngorhinootologie 78:63-67
46. Teed RW (1936) Cholesteatoma verum tympani: its relationship to the first epibranchial placode. Arch Otolaryngol 24:455-474
47. Thewes M, Stadler R, Korge B, Mischke D (1991) Normal psoriatic epidermis of hyperproliferation-associated keratins. Arch Dermatol Res 283:465-471
48. Tseng SCG, Jarvinen MG, Nelson WG, Woodcock-Mitchell J, Sun TT (1982) Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell 30:361-372
49. van Blitterswijk CA, Grote JJ, Lutgert RW, Hesseling SC, Out CJ, Van Muijen GN, Fransen JA (1989) Cytokeratin patterns of tissues related to cholesteatoma pathogenesis. Ann Otol Rhinol Laryngol 98:635-640
50. Vennix PP, Kuijpers W, Peters TA, Tonnaer EL, Ramaekers FC (1996) Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes. Arch Otolaryngol Head Neck Surg 122:825-832
51. Weiss RA, Guillet GYA, Freedberg IM, Farmer ER, Small EA, Weiss MM, Sun TT (1983) The use of monoclonal antibody to keratin in human epidermal disease: alterations in immunohistochemical staining pattern. J Invest Dermatol 81:224-230
52. Weiss RA, Eichner R, Sun T (1984) Monoclonal antibody analysis of keratin expression in epidermal disease: a 48- and 56-k dalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol 98:1397-1406
53. Wolfman DE, Chole RA (1986) Experimental retraction pocket cholesteatoma. Ann Otol Rhinol Laryngol 95: 639-644